4//SEC Filing
Witter Malcolm G 4
Accession 0001437749-22-021742
CIK 0000810509other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 9:46 PM ET
Size
9.6 KB
Accession
0001437749-22-021742
Insider Transaction Report
Form 4
Witter Malcolm G
Director
Transactions
- Purchase
Series I Convertible Preferred Stock
2022-08-30+115→ 115 totalExercise: $0.45From: 2022-08-30→ Common Stock (255,530 underlying) - Award
Common Stock
2022-08-31+2,500→ 158,888 total - Purchase
Warrant to Purchase Common Stock
2022-08-30+115→ 115 totalExercise: $0.50From: 2022-08-30Exp: 2027-08-30→ Common Stock (255,530 underlying)
Footnotes (4)
- [F1]Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
- [F2]Issuance deferred at the request of the Reporting Person.
- [F3]The Reporting Person acquired the Series I Convertible Preferred Stock and Warrants to Purchase Common Stock pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering ("Rights Offering"), as disclosed in the Registration Statement on Form S-1, as amended, and Prospectus Supplement No. 1 filed by the Issuer with the Securities and Exchange Commission. Pursuant to the Rights Offering, the Reporting Person purchased units at a subscription price of $1,000 per unit, with each unit consisting of one (1) share of Series I Convertible Preferred Stock and one (1) Warrant to Purchase 2,222 shares of Common Stock.
- [F4]Series I Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001838283
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 9:46 PM ET
- Size
- 9.6 KB